Dai HS*, Caligiuri MA*. Molecular basis for the interaction between HSV1 infection and human NK cells. Front Immunol. 2018 Feb 12;9:183. (* co-corresponding author)
Dai HS*, Griffin N, Bolyard C, Mao C, Zhang J, Cripe T, Suenaga T, Arase H, Nakano I, Chiocca E, Kaur B, Yu J, Caligiuri MA*. (2017).The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells. Immunity. Jul; 47 (1): 159-170 (* co-corresponding author)
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai HS, Nallanagulagari T, Wojton J, Hurwitz BS, Relation T, Lee TJ, Lotze MT, Yu JG, Zhang J, Croce CM, Yu J, Caligiuri MA, Old M, Kaur B. (2016).Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy. Clin Cancer Res. Nov 1;22(21):5265-5276.
Dai HS*, Liu Z, Jiang W, Kuhn RJ*. (2013). Directed evolution of a virus exclusively utilizing human epidermal growth factor receptor as the entry receptor. J Virol. Oct;87(20):11231-43. (* co-corresponding author)
